Back to Hood River Capital Management LLC Hood River Capital Management LLC

KPTIKPTI

Showing 0 of 9 quarters

Position history for Hood River Capital Management LLCHood River Capital Management LLC's holdings in Karyopharm Therapeutics Inc.

No. Hood River Capital Management exited its KPTI (Karyopharm Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 802,246 shares worth $8.3M. Hood River Capital Management first reported KPTI in Q3 2019 and held it in 8 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used